XTNT insider transaction filings
Xtant Medical Holdings, Inc. — 39 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen XTNT transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 8 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Browne Sean E — President and CEO, Director | 1 | — | — | 2 |
| Neils Scott C — CFO and Assistant Secretary | 1 | — | — | 2 |
| Schallenberger Mark A. — Chief Operating Officer | 1 | — | — | 2 |
| BAKEWELL JOHN K — Director | 1 | — | — | 1 |
| Beeson Jonn R. — Director | 1 | — | — | 1 |
| JAIN ABHINAV — Director | 1 | — | — | 1 |
| Lipschultz Tyler — Director | 1 | — | — | 1 |
| Vizirgianakis Stavros G. — Director | 1 | — | — | 1 |
Recent Form 4 filings — Xtant Medical Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Lipschultz Tyler — Director | Grant/award (A): 215,517 @ $0 | EDGAR |
| 2026-08-18 | 4 | BAKEWELL JOHN K — Director | Grant/award (A): 215,517 @ $0 | EDGAR |
| 2026-08-18 | 4 | Beeson Jonn R. — Director | Grant/award (A): 215,517 @ $0 | EDGAR |
| 2026-08-18 | 4 | JAIN ABHINAV — Director | Grant/award (A): 215,517 @ $0 | EDGAR |
| 2026-08-18 | 4 | Vizirgianakis Stavros G. — Director | Grant/award (A): 323,275 @ $0 | EDGAR |
| 2026-08-18 | 4 | Schallenberger Mark A. — Chief Operating Officer | Grant/award (A): 450,000 @ $0 · Tax withholding (F): 7,070 @ $0.31 | EDGAR |
| 2026-08-18 | 4 | Neils Scott C — CFO and Assistant Secretary | Grant/award (A): 400,000 @ $0 · Tax withholding (F): 28,155 @ $0.31 | EDGAR |
| 2026-08-18 | 4 | Browne Sean E — President and CEO, Director | Grant/award (A): 550,000 @ $0 · Tax withholding (F): 10,605 @ $0.31 | EDGAR |
| 2026-02-18 | 4 | Schallenberger Mark A. — Chief Operating Officer | Tax withholding (F): 7,709 @ $0.58 | EDGAR |
| 2026-01-16 | 4 | Neils Scott C — CFO and Assistant Secretary | Tax withholding (F): 8,084 @ $0.65 | EDGAR |
| 2025-11-18 | 4 | JAIN ABHINAV — Director | Grant/award (A): 158,228 @ $0 | EDGAR |
| 2025-11-18 | 4 | Beeson Jonn R. — Director | Grant/award (A): 158,228 @ $0 | EDGAR |
| 2025-11-18 | 4 | Schallenberger Mark A. — Chief Operating Officer | Grant/award (A): 292,253 @ $0 · Grant/award (A): 584,506 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Neils Scott C — CFO and Assistant Secretary | Grant/award (A): 263,291 @ $0 · Grant/award (A): 526,582 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Browne Sean E — President and CEO, Director | Grant/award (A): 394,937 @ $0 · Grant/award (A): 789,874 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Vizirgianakis Stavros G. — Director | Grant/award (A): 553,797 @ $0 | EDGAR |
| 2025-11-18 | 4 | Lipschultz Tyler — Director | Grant/award (A): 158,228 @ $0 | EDGAR |
| 2025-11-18 | 4 | BAKEWELL JOHN K — Director | Grant/award (A): 158,228 @ $0 | EDGAR |
| 2025-11-18 | 4/A | BAKEWELL JOHN K — Director | Grant/award (A): 158,228 @ $0 | EDGAR |
| 2025-08-19 | 4 | Browne Sean E — President and CEO, Director | Tax withholding (F): 10,605 @ $0.63 | EDGAR |
| 2025-08-19 | 4 | Neils Scott C — CFO | Tax withholding (F): 34,131 @ $0.63 | EDGAR |
| 2025-04-14 | 4 | ORBIMED ADVISORS LLC — 10% owner Orbimed ROF II LLC — 10% owner | Sale (S): 56,004,974 @ $0.42 · Sale (S): 17,109,618 @ $0.42 | EDGAR |
| 2025-01-17 | 4 | Neils Scott C — Chief Financial Officer | Tax withholding (F): 7,986 @ $0.53 | EDGAR |
| 2025-01-17 | 4/A | Schallenberger Mark A. — Chief Operations Officer | Grant/award (A): 173,469 @ $0 | EDGAR |
| 2024-10-16 | 4 | Browne Sean E — President and CEO, Director | Tax withholding (F): 105,442 @ $0.59 | EDGAR |
| 2024-08-19 | 4 | Vizirgianakis Stavros G. — Director | Grant/award (A): 243,243 @ $0 · Grant/award (A): 505,405 @ $0 | EDGAR |
| 2024-08-19 | 4 | Beeson Jonn R. — Director | Grant/award (A): 162,162 @ $0 | EDGAR |
| 2024-08-19 | 4 | Brandt Kevin D — Chief Commercial Officer | Tax withholding (F): 56,333 @ $0.60 | EDGAR |
| 2024-08-19 | 4 | Neils Scott C — Chief Financial Officer | Tax withholding (F): 34,132 @ $0.60 | EDGAR |
| 2024-08-19 | 4 | Browne Sean E — President and CEO, Director | Tax withholding (F): 10,606 @ $0.60 | EDGAR |
| 2024-08-19 | 4 | McNamara Robert — Director | Grant/award (A): 162,162 @ $0 | EDGAR |
| 2024-08-19 | 4 | MITCHELL-KELLER LORI D — Director | Grant/award (A): 162,162 @ $0 | EDGAR |
| 2024-08-19 | 4 | BAKEWELL JOHN K — Director | Grant/award (A): 162,162 @ $0 | EDGAR |
| 2024-04-05 | 4 | Neils Scott C — Chief Financial Officer | Grant/award (A): 177,551 @ $0 | EDGAR |
| 2024-04-05 | 4 | Brandt Kevin D — Chief Commercial Officer | Grant/award (A): 184,209 @ $0 | EDGAR |
| 2024-04-05 | 4 | Browne Sean E — President and CEO, Director | Grant/award (A): 731,632 @ $0 | EDGAR |
| 2024-04-05 | 4 | Schallenberger Mark A. — Chief Operations Officer | Grant/award (A): 177,551 @ $0 | EDGAR |
| 2024-02-16 | 4/A | Browne Sean E — President and CEO, Director | Tax withholding (F): 105,442 @ $1.08 | EDGAR |
| 2024-01-18 | 4 | Neils Scott C — Chief Financial Officer | Tax withholding (F): 7,986 @ $1.09 | EDGAR |
Recent 8-K events — Xtant Medical Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-13 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-01-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-12-03 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=XTNT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →